3F7-16809-83052 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-07-02
Dose 1 — Pfizer-BioNTech
2022-07-04
Registered in v-safe
2022-07-04
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Fair · Fever · Sleepiness, Loss of appetite

Under 3 check-in
2022-07-05
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · Fever · Sleepiness

Under 3 check-in
2022-07-06
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · Fever · None

Under 3 check-in
2022-07-07
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Poor · Fever · Sleepiness, Vomiting · Be unable to work or attend school, Be unable to do your normal daily activities

Under 3 check-in
2022-07-09
Health check-in — day 7, dose 1, under 3
Feeling: Good · Fever · None

Under 3 check-in
2022-07-16
Health check-in — day 14, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-07-23
Dose 2 — Pfizer-BioNTech
2022-08-06
Survey response — day 14, dose 2, under 3
MedDRA: Cough, Rhinorrhoea, Vomiting — Feeling: Good · Be unable to work or attend school

Free text: Runny nose, cough, vomiting

MedDRA releases: 2024-11 · check-in free text available
2022-08-13
Health check-in — day 21, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-08-20
Health check-in — day 28, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-08-27
Health check-in — day 35, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-09-03
Survey response — day 42, dose 2, under 3
MedDRA: Respiratory tract infection, SARS-CoV-2 test negative — Feeling: Good · Be unable to do your normal daily activities

Free text: Respiratory infection. Not covid by PCR

MedDRA releases: 2024-11 · check-in free text available
2022-09-21
Dose 3 — Pfizer-BioNTech
2022-10-02
Health check-in — day 7, dose 3, under 3
Feeling: Good · None

Under 3 check-in
2022-10-06
Health check-in — day 14, dose 3, under 3
Feeling: Good

Under 3 check-in
2022-10-12
Health check-in — day 21, dose 3, under 3
Feeling: Good

Under 3 check-in
2022-10-19
Health check-in — day 28, dose 3, under 3
Feeling: Good

Under 3 check-in
2022-10-26
Survey response — day 35, dose 3, under 3
MedDRA: Respiratory syncytial virus infection — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Respiratory infection. Suspected RSV.

MedDRA releases: 2024-11 · check-in free text available
2022-10-26
Report sent to call center — day 35, dose 3, under 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-10-27
Call 1 — Left Voicemail
2022-11-02
Health check-in — day 42, dose 3, under 3
Feeling: Good

Under 3 check-in
2022-12-21
Survey response — 3 months, dose 3, under 3
MedDRA: Asthma, Emergency care, Illness, Pre-existing disease — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit

Free text: Non covid illness. Asthma flare requiring ED visit

MedDRA releases: 2024-11 · check-in free text available
2022-12-21
Report sent to call center — 3 months, dose 3, under 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
2022-12-22
Call successful
Does not wish to fill out VAERS report
2022-12-22
Call successful
Does not wish to fill out VAERS report
2023-03-22
Health check-in — 6 months, dose 3, under 3
Feeling: Good

Under 3 check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-07-02	Pfizer-BioNTech	No
2	2022-07-23	Pfizer-BioNTech	No
3	2022-09-21	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2022-10-26	Successful 2022-12-22	Does not wish to fill out VAERS report
2022-12-21	Successful 2022-12-22	Does not wish to fill out VAERS report

Free text

Release 12 (Under 3) — day 14, dose 2, under 3

2022-08-06

Symptoms: Runny nose, cough, vomiting

Release 12 (Under 3) — day 42, dose 2, under 3

2022-09-03

Symptoms: Respiratory infection. Not covid by PCR

Release 12 (Under 3) — day 35, dose 3, under 3

2022-10-26

Symptoms: Respiratory infection. Suspected RSV.

Release 12 (Under 3) — 3 months, dose 3, under 3

2022-12-21

Symptoms: Non covid illness. Asthma flare requiring ED visit

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Asthma	·	·	✓
SD	Cough	·	·	✓
SD	Emergency care	·	·	✓
SD	Illness	·	·	✓
SD	Pre-existing disease	·	·	✓
SD	Respiratory syncytial virus infection	·	·	✓
SD	Respiratory tract infection	·	·	✓
SD	Rhinorrhoea	·	·	✓
SD	SARS-CoV-2 test negative	·	·	✓
SD	Vomiting	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release